Clinical Trial Update: Pentoxifylline for Treatment of Resistant Major Depression [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating pentoxifylline for treatment of resistant major depression has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Pentoxifylline (pentoxifylline)

Snippet

Sponsor: Hawler Medical University | Conditions: Resistant Major Depression | Phase 1, Phase 2 | Status: COMPLETED